Superior efficacy of St John's wort extract WS(® )5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]

BACKGROUND: The aim of the current study was to assess the antidepressant efficacy and safety of Hypericum perforatum (St. John's wort) extract WS(® )5570 at doses of 600 mg/day in a single dose and 1200 mg/day in two doses. METHODS: The participants in this double-blind, randomized, placebo-co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasper, Siegfried, Anghelescu, Ion-George, Szegedi, Armin, Dienel, Angelika, Kieser, Meinhard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1538611/
https://www.ncbi.nlm.nih.gov/pubmed/16796730
http://dx.doi.org/10.1186/1741-7015-4-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1538611/
https://www.ncbi.nlm.nih.gov/pubmed/16796730
http://dx.doi.org/10.1186/1741-7015-4-14

Ejemplares similares